Latest Refining News

Sunshine Metals has increased its Liontown shallow gold resource by 14% to 108,000 ounces, advancing its pathway to near-term production in 2026. High-grade drilling results at the Sybil prospect and new VMS targets further strengthen the company’s exploration outlook.

Cyclopharm’s Technegas has been recognised as the preferred ventilation agent in a pivotal draft US lung imaging guideline, signalling a major boost for its adoption in American clinical practice.

Axel REE Limited’s latest metallurgical tests have doubled gallium extraction rates at its Caladão Project and revealed the first evidence of scandium co-recovery, signalling a promising new revenue stream.

Nova Minerals has secured US$43.4 million in non-dilutive funding from the U.S. Department of War to fully fund its domestic antimony supply chain development in Alaska, while also progressing its vast Estelle gold project with promising drilling results.

Biome Australia Limited has delivered its strongest quarterly financial performance to date, with sales revenue surging 41% year-on-year to $6.5 million and maintaining eight consecutive quarters of positive EBITDA.

iTech Minerals reports significant gold and antimony intersections from recent drilling at Reynolds Range, Northern Territory, alongside a new magnetic survey expanding exploration targets.

Mont Royal Resources has signed a non-binding Memorandum of Understanding with the Saguenay Port Authority to explore locating a hydrometallurgical facility for its Ashram Rare Earths Project in Québec, leveraging the port’s strategic logistics and industrial infrastructure.

Litchfield Minerals is set to commence a comprehensive airborne magnetic and radiometric survey over its Lucy Creek Project in the Northern Territory, aiming to unlock high-grade manganese potential in an underexplored sedimentary basin.

Dateline Resources has completed a pivotal geophysical survey at its Colosseum Gold and Rare Earth Elements project in California, revealing promising deep sulphide mineralisation zones that could expand its gold and rare earth resource base.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.

Nordic Resources has identified a previously unknown higher-grade gold-copper zone at its Kopsa project in Finland, expanding the potential of the deposit beyond current resource boundaries.

Cygnus Metals reports robust high-grade drill results outside its existing resource at the Chibougamau Copper-Gold Project, driving a 29% increase in global resource and advancing economic studies.